Novel motif:64: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{Novel_motif
|name=motif64_AGTCGN
|novel_motifs_human_sample_pval=11376-118A8_11051;0.229663,11327-117E4_11969;0.694717,11473-119C6_11054;0.231524,11474-119C7_12067;0.70032...") |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 14:51, 9 September 2013
name: | motif64_AGTCGN |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0006348 | chromatin silencing at telomere | 3.457724e-10 |
GO:0043503 | skeletal muscle fiber adaptation | 1.122863e-8 |
GO:0070145 | mitochondrial asparaginyl-tRNA aminoacylation | 8.131372e-8 |
GO:0043501 | skeletal muscle adaptation | 1.438361e-7 |
GO:0021569 | rhombomere 3 development | 1.219738e-6 |
GO:0042696 | menarche | 1.776844e-6 |
GO:0021759 | globus pallidus development | 1.967132e-6 |
GO:0061003 | positive regulation of dendritic spine morphogenesis | 2.799773e-6 |
GO:0061084 | negative regulation of protein refolding | 2.985237e-6 |
GO:0006768 | biotin metabolic process | 3.671677e-6 |
GO:0042538 | hyperosmotic salinity response | 4.495209e-6 |
GO:0090342 | regulation of cell aging | 7.402089e-6 |
GO:0006482 | protein demethylation | 1.085974e-5 |
GO:0021658 | rhombomere 3 morphogenesis | 1.158877e-5 |
GO:0030505 | inorganic diphosphate transport | 1.559096e-5 |
GO:0007181 | transforming growth factor beta receptor complex assembly | 1.664425e-5 |
GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development | 1.828574e-5 |
GO:0007379 | segment specification | 1.839390e-5 |
GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 1.847398e-5 |
GO:0060999 | positive regulation of dendritic spine development | 1.946510e-5 |
GO:0014888 | striated muscle adaptation | 2.551657e-5 |
GO:0016140 | O-glycoside metabolic process | 3.936343e-5 |
GO:0046796 | viral genome transport in host cell | 4.053387e-5 |
GO:0035845 | photoreceptor cell outer segment organization | 4.792674e-5 |
GO:0051318 | G1 phase | 5.356445e-5 |
GO:0035435 | phosphate ion transmembrane transport | 5.399853e-5 |
GO:0042073 | intraflagellar transport | 5.890903e-5 |
GO:0008049 | male courtship behavior | 6.461061e-5 |
GO:0010459 | negative regulation of heart rate | 8.183187e-5 |
GO:0002016 | regulation of blood volume by renin-angiotensin | 9.628307e-5 |
GO:0021591 | ventricular system development | 9.998682e-5 |
GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing | 1.071244e-4 |
GO:0006400 | tRNA modification | 1.107425e-4 |
GO:0060179 | male mating behavior | 1.121486e-4 |
GO:0006817 | phosphate ion transport | 1.166152e-4 |
GO:0070127 | tRNA aminoacylation for mitochondrial protein translation | 1.180828e-4 |
GO:2000772 | regulation of cellular senescence | 1.451720e-4 |
GO:0060347 | heart trabecula formation | 1.484740e-4 |
GO:0021670 | lateral ventricle development | 1.487243e-4 |
GO:0072268 | pattern specification involved in metanephros development | 1.540262e-4 |
GO:0070389 | chaperone cofactor-dependent protein refolding | 1.553187e-4 |
GO:0071169 | establishment of protein localization to chromatin | 1.606811e-4 |
GO:0042255 | ribosome assembly | 1.664741e-4 |
GO:0097045 | phosphatidylserine exposure on blood platelet | 1.725864e-4 |
GO:0051775 | response to redox state | 1.917171e-4 |
GO:0000183 | chromatin silencing at rDNA | 1.917171e-4 |
GO:0000966 | RNA 5'-end processing | 2.056850e-4 |
GO:0021877 | forebrain neuron fate commitment | 2.083432e-4 |
GO:0019318 | hexose metabolic process | 2.128347e-4 |
GO:0060017 | parathyroid gland development | 2.251259e-4 |
GO:0021546 | rhombomere development | 2.500577e-4 |
GO:0006379 | mRNA cleavage | 2.541786e-4 |
GO:0016577 | histone demethylation | 2.574813e-4 |
GO:0021599 | abducens nerve formation | 2.984188e-4 |
GO:0007634 | optokinetic behavior | 2.984188e-4 |
GO:0050746 | regulation of lipoprotein metabolic process | 3.041888e-4 |
GO:0021612 | facial nerve structural organization | 3.128685e-4 |
GO:0000080 | G1 phase of mitotic cell cycle | 3.274508e-4 |
GO:0051013 | microtubule severing | 3.423759e-4 |
GO:0010871 | negative regulation of receptor biosynthetic process | 3.610360e-4 |
GO:0070988 | demethylation | 3.687038e-4 |
GO:0061384 | heart trabecular morphogenesis | 3.857675e-4 |
GO:0035721 | intraflagellar retrograde transport | 4.246168e-4 |
GO:0032472 | Golgi calcium ion transport | 4.246168e-4 |
GO:0032468 | Golgi calcium ion homeostasis | 4.246168e-4 |
GO:0030026 | cellular manganese ion homeostasis | 4.246168e-4 |
GO:0001757 | somite specification | 4.286324e-4 |
GO:0046543 | development of secondary female sexual characteristics | 4.351880e-4 |
GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 4.453941e-4 |
GO:0032623 | interleukin-2 production | 4.505100e-4 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 5.118066e-4 |
GO:0042026 | protein refolding | 5.429349e-4 |
GO:0018872 | arsonoacetate metabolic process | 5.714611e-4 |
GO:0045007 | depurination | 5.801260e-4 |
GO:0060807 | regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification | 5.801260e-4 |
GO:0006680 | glucosylceramide catabolic process | 5.801260e-4 |
GO:0003142 | cardiogenic plate morphogenesis | 5.801260e-4 |
GO:0048702 | embryonic neurocranium morphogenesis | 6.229685e-4 |
GO:0090344 | negative regulation of cell aging | 6.259248e-4 |
GO:0002606 | positive regulation of dendritic cell antigen processing and presentation | 6.903425e-4 |
GO:0045136 | development of secondary sexual characteristics | 7.514193e-4 |
GO:0015887 | pantothenate transmembrane transport | 7.547912e-4 |
GO:0015878 | biotin transport | 7.547912e-4 |
GO:2000251 | positive regulation of actin cytoskeleton reorganization | 7.644616e-4 |
GO:0007109 | cytokinesis, completion of separation | 7.670216e-4 |
GO:0060998 | regulation of dendritic spine development | 8.000807e-4 |
GO:0021542 | dentate gyrus development | 8.268396e-4 |
GO:0005996 | monosaccharide metabolic process | 8.389549e-4 |
GO:0035574 | histone H4-K20 demethylation | 9.354166e-4 |
GO:0071557 | histone H3-K27 demethylation | 9.354166e-4 |
GO:0021798 | forebrain dorsal/ventral pattern formation | 9.489616e-4 |
GO:0006006 | glucose metabolic process | 9.962437e-4 |
GO:0034660 | ncRNA metabolic process | 1.010109e-3 |
GO:0035873 | lactate transmembrane transport | 1.028067e-3 |
GO:2000773 | negative regulation of cellular senescence | 1.062021e-3 |
GO:0043697 | cell dedifferentiation | 1.062021e-3 |
GO:0060977 | coronary vasculature morphogenesis | 1.067495e-3 |
GO:0006096 | glycolysis | 1.071649e-3 |
GO:0016142 | O-glycoside catabolic process | 1.076222e-3 |
GO:0048752 | semicircular canal morphogenesis | 1.086458e-3 |
GO:0014916 | regulation of lung blood pressure | 1.097897e-3 |
GO:0035871 | protein K11-linked deubiquitination | 1.124832e-3 |
GO:0009303 | rRNA transcription | 1.146735e-3 |
GO:0035284 | brain segmentation | 1.221167e-3 |
GO:0006369 | termination of RNA polymerase II transcription | 1.325516e-3 |
GO:0032425 | positive regulation of mismatch repair | 1.337143e-3 |
GO:0061001 | regulation of dendritic spine morphogenesis | 1.373478e-3 |
GO:0042094 | interleukin-2 biosynthetic process | 1.463869e-3 |
GO:0007172 | signal complex assembly | 1.475023e-3 |
GO:0046950 | cellular ketone body metabolic process | 1.551341e-3 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 1.583467e-3 |
GO:0042732 | D-xylose metabolic process | 1.721676e-3 |
GO:0032423 | regulation of mismatch repair | 1.783836e-3 |
GO:0060466 | activation of meiosis involved in egg activation | 1.830882e-3 |
GO:0033057 | multicellular organismal reproductive behavior | 1.856154e-3 |
GO:0034214 | protein hexamerization | 1.929693e-3 |
GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 2.005869e-3 |
GO:0051329 | interphase of mitotic cell cycle | 2.010969e-3 |
GO:2000824 | negative regulation of androgen receptor activity | 2.014548e-3 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 2.062026e-3 |
GO:0000729 | DNA double-strand break processing | 2.072367e-3 |
GO:0051325 | interphase | 2.148827e-3 |
GO:0042886 | amide transport | 2.179855e-3 |
GO:0009404 | toxin metabolic process | 2.199337e-3 |
GO:0002579 | positive regulation of antigen processing and presentation | 2.220211e-3 |
GO:0031122 | cytoplasmic microtubule organization | 2.261304e-3 |
GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process | 2.264967e-3 |
GO:0033326 | cerebrospinal fluid secretion | 2.282142e-3 |
GO:0017121 | phospholipid scrambling | 2.321767e-3 |
GO:0031591 | wybutosine biosynthetic process | 2.333842e-3 |
GO:0006710 | androgen catabolic process | 2.333842e-3 |
GO:0060876 | semicircular canal formation | 2.339180e-3 |
GO:0002543 | activation of blood coagulation via clotting cascade | 2.365419e-3 |
GO:0045842 | positive regulation of mitotic metaphase/anaphase transition | 2.490871e-3 |
GO:0046690 | response to tellurium ion | 2.611212e-3 |
GO:0009645 | response to low light intensity stimulus | 2.611212e-3 |
GO:0006828 | manganese ion transport | 2.822585e-3 |
GO:0006421 | asparaginyl-tRNA aminoacylation | 2.822835e-3 |
GO:0042984 | regulation of amyloid precursor protein biosynthetic process | 2.838552e-3 |
GO:0018206 | peptidyl-methionine modification | 2.858590e-3 |
GO:0030433 | ER-associated protein catabolic process | 2.940312e-3 |
GO:0046474 | glycerophospholipid biosynthetic process | 2.996903e-3 |
GO:0021523 | somatic motor neuron differentiation | 3.224350e-3 |
GO:0060596 | mammary placode formation | 3.313350e-3 |
GO:0021778 | oligodendrocyte cell fate specification | 3.344338e-3 |
GO:0021526 | medial motor column neuron differentiation | 3.348168e-3 |
GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process | 3.421850e-3 |
GO:0072303 | positive regulation of glomerular metanephric mesangial cell proliferation | 3.451949e-3 |
GO:0048193 | Golgi vesicle transport | 3.463297e-3 |
GO:0006730 | one-carbon metabolic process | 3.591683e-3 |
GO:0035117 | embryonic arm morphogenesis | 3.594303e-3 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 3.630971e-3 |
GO:0035545 | determination of left/right asymmetry in nervous system | 3.791725e-3 |
GO:0007208 | activation of phospholipase C activity by serotonin receptor signaling pathway | 3.791725e-3 |
GO:0060580 | ventral spinal cord interneuron fate determination | 3.850247e-3 |
GO:0003327 | type B pancreatic cell fate commitment | 3.850247e-3 |
GO:0046853 | inositol or phosphatidylinositol phosphorylation | 3.850247e-3 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 3.855050e-3 |
GO:0021571 | rhombomere 5 development | 3.889961e-3 |
GO:0006003 | fructose 2,6-bisphosphate metabolic process | 3.889961e-3 |
GO:0010771 | negative regulation of cell morphogenesis involved in differentiation | 3.917805e-3 |
GO:0045870 | positive regulation of retroviral genome replication | 3.931144e-3 |
GO:0097037 | heme export | 3.931144e-3 |
GO:0002033 | vasodilation by angiotensin involved in regulation of systemic arterial blood pressure | 3.931144e-3 |
GO:0021892 | cerebral cortex GABAergic interneuron differentiation | 3.937895e-3 |
GO:0045342 | MHC class II biosynthetic process | 4.137802e-3 |
GO:0070839 | divalent metal ion export | 4.137802e-3 |
GO:0043091 | L-arginine import | 4.137802e-3 |
GO:0006876 | cellular cadmium ion homeostasis | 4.137802e-3 |
GO:0015707 | nitrite transport | 4.137802e-3 |
GO:0032632 | interleukin-3 production | 4.137802e-3 |
GO:0061014 | positive regulation of mRNA catabolic process | 4.228162e-3 |
GO:0070534 | protein K63-linked ubiquitination | 4.281108e-3 |
GO:0032222 | regulation of synaptic transmission, cholinergic | 4.351817e-3 |
GO:0048714 | positive regulation of oligodendrocyte differentiation | 4.516087e-3 |
GO:0006013 | mannose metabolic process | 4.627209e-3 |
GO:0061013 | regulation of mRNA catabolic process | 4.680454e-3 |
GO:0042772 | DNA damage response, signal transduction resulting in transcription | 4.680454e-3 |
GO:0060816 | random inactivation of X chromosome | 4.730841e-3 |
GO:0009155 | purine deoxyribonucleotide catabolic process | 4.904239e-3 |
GO:0021779 | oligodendrocyte cell fate commitment | 4.959719e-3 |
GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process | 5.010796e-3 |
GO:0006458 | 'de novo' protein folding | 5.022182e-3 |
GO:0046884 | follicle-stimulating hormone secretion | 5.042513e-3 |
GO:0032275 | luteinizing hormone secretion | 5.042513e-3 |
GO:0060390 | regulation of SMAD protein import into nucleus | 5.200778e-3 |
GO:0046364 | monosaccharide biosynthetic process | 5.243772e-3 |
GO:0034498 | early endosome to Golgi transport | 5.353652e-3 |
GO:0006000 | fructose metabolic process | 5.368065e-3 |
GO:0072086 | specification of loop of Henle identity | 5.401268e-3 |
GO:0051923 | sulfation | 5.492343e-3 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 5.543571e-3 |
GO:0071506 | cellular response to mycophenolic acid | 5.639173e-3 |
GO:0072126 | positive regulation of glomerular mesangial cell proliferation | 5.639173e-3 |
GO:0061002 | negative regulation of dendritic spine morphogenesis | 5.639173e-3 |
GO:0055017 | cardiac muscle tissue growth | 5.684804e-3 |
GO:0008617 | guanosine metabolic process | 5.699764e-3 |
GO:0034470 | ncRNA processing | 5.703010e-3 |
GO:0000278 | mitotic cell cycle | 5.753724e-3 |
GO:0010719 | negative regulation of epithelial to mesenchymal transition | 5.789151e-3 |
GO:0034227 | tRNA thio-modification | 5.824641e-3 |
GO:0002098 | tRNA wobble uridine modification | 5.824641e-3 |
GO:0034637 | cellular carbohydrate biosynthetic process | 6.053569e-3 |
GO:0021754 | facial nucleus development | 6.078632e-3 |
GO:0071514 | genetic imprinting | 6.092200e-3 |
GO:0015886 | heme transport | 6.120432e-3 |
GO:0043631 | RNA polyadenylation | 6.144442e-3 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 6.200942e-3 |
GO:0006477 | protein sulfation | 6.268809e-3 |
GO:0002035 | brain renin-angiotensin system | 6.269162e-3 |
GO:0006094 | gluconeogenesis | 6.304119e-3 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 6.309374e-3 |
GO:0015840 | urea transport | 6.335267e-3 |
GO:0006281 | DNA repair | 6.388607e-3 |
GO:0000738 | DNA catabolic process, exonucleolytic | 6.424745e-3 |
GO:0072081 | specification of nephron tubule identity | 6.461725e-3 |
GO:0000460 | maturation of 5.8S rRNA | 6.478961e-3 |
GO:0043105 | negative regulation of GTP cyclohydrolase I activity | 6.601444e-3 |
GO:0010624 | regulation of Schwann cell proliferation | 6.703880e-3 |
GO:0051181 | cofactor transport | 6.953263e-3 |
GO:0007089 | traversing start control point of mitotic cell cycle | 7.105735e-3 |
GO:0006684 | sphingomyelin metabolic process | 7.168169e-3 |
GO:0034699 | response to luteinizing hormone stimulus | 7.212628e-3 |
GO:0021666 | rhombomere 5 formation | 7.212628e-3 |
GO:0021660 | rhombomere 3 formation | 7.212628e-3 |
GO:0006408 | snRNA export from nucleus | 7.212628e-3 |
GO:0006478 | peptidyl-tyrosine sulfation | 7.212628e-3 |
GO:0032383 | regulation of intracellular cholesterol transport | 7.268584e-3 |
GO:0085020 | protein K6-linked ubiquitination | 7.301817e-3 |
GO:0048102 | autophagic cell death | 7.301817e-3 |
GO:0033578 | protein glycosylation in Golgi | 7.367239e-3 |
GO:0060913 | cardiac cell fate determination | 7.367239e-3 |
GO:0060038 | cardiac muscle cell proliferation | 7.392624e-3 |
GO:0016339 | calcium-dependent cell-cell adhesion | 7.540847e-3 |
GO:0090136 | epithelial cell-cell adhesion | 7.591691e-3 |
GO:0070925 | organelle assembly | 7.617874e-3 |
GO:0060419 | heart growth | 7.890523e-3 |
GO:0030953 | astral microtubule organization | 7.948467e-3 |
GO:0090129 | positive regulation of synapse maturation | 8.290778e-3 |
GO:0009996 | negative regulation of cell fate specification | 8.319812e-3 |
GO:0097118 | neuroligin clustering | 8.422146e-3 |
GO:0021610 | facial nerve morphogenesis | 8.422146e-3 |
GO:0022601 | menstrual cycle phase | 8.586325e-3 |
GO:0006552 | leucine catabolic process | 8.625782e-3 |
GO:0043456 | regulation of pentose-phosphate shunt | 8.890221e-3 |
GO:0031860 | telomeric 3' overhang formation | 8.890221e-3 |
GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation | 8.890221e-3 |
GO:0060980 | cell migration involved in coronary vasculogenesis | 8.949886e-3 |
GO:0043622 | cortical microtubule organization | 9.021746e-3 |
GO:0046833 | positive regulation of RNA export from nucleus | 9.021746e-3 |
GO:0030103 | vasopressin secretion | 9.021746e-3 |
GO:0031658 | negative regulation of cyclin-dependent protein kinase activity involved in G1/S | 9.021746e-3 |
GO:0007092 | activation of mitotic anaphase-promoting complex activity | 9.021746e-3 |
GO:0006734 | NADH metabolic process | 9.069661e-3 |
GO:0072110 | glomerular mesangial cell proliferation | 9.237516e-3 |
GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis | 9.290636e-3 |
GO:0021570 | rhombomere 4 development | 9.290636e-3 |
GO:0021568 | rhombomere 2 development | 9.290636e-3 |
GO:0055015 | ventricular cardiac muscle cell development | 9.380822e-3 |
GO:0006551 | leucine metabolic process | 9.531957e-3 |
GO:0032218 | riboflavin transport | 9.543159e-3 |
GO:0021586 | pons maturation | 9.543159e-3 |
GO:0090343 | positive regulation of cell aging | 9.632577e-3 |
GO:0019319 | hexose biosynthetic process | 9.700416e-3 |
GO:0006654 | phosphatidic acid biosynthetic process | 9.800237e-3 |
GO:0032825 | positive regulation of natural killer cell differentiation | 9.868293e-3 |
GO:0033169 | histone H3-K9 demethylation | 9.908811e-3 |
GO:0009262 | deoxyribonucleotide metabolic process | 9.920479e-3 |
GO:0048255 | mRNA stabilization | 9.939885e-3 |
GO:0048664 | neuron fate determination | 1.016131e-2 |
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.016370e-2 |
GO:0006349 | regulation of gene expression by genetic imprinting | 1.019913e-2 |
GO:0042254 | ribosome biogenesis | 1.031683e-2 |
GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter | 1.073610e-2 |
GO:0046080 | dUTP metabolic process | 1.073610e-2 |
GO:0002309 | T cell proliferation involved in immune response | 1.073610e-2 |
GO:0030208 | dermatan sulfate biosynthetic process | 1.076518e-2 |
GO:0021592 | fourth ventricle development | 1.086602e-2 |
GO:0070574 | cadmium ion transmembrane transport | 1.154996e-2 |
GO:0060872 | semicircular canal development | 1.158669e-2 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 1.158669e-2 |
GO:0006107 | oxaloacetate metabolic process | 1.172760e-2 |
GO:0070544 | histone H3-K36 demethylation | 1.179363e-2 |
GO:0000724 | double-strand break repair via homologous recombination | 1.180034e-2 |
GO:0045739 | positive regulation of DNA repair | 1.184835e-2 |
GO:0009451 | RNA modification | 1.225925e-2 |
GO:0070535 | histone H2A K63-linked ubiquitination | 1.267178e-2 |
GO:0042228 | interleukin-8 biosynthetic process | 1.267178e-2 |
GO:0046587 | positive regulation of calcium-dependent cell-cell adhesion | 1.267178e-2 |
GO:0006471 | protein ADP-ribosylation | 1.277813e-2 |
GO:0072321 | chaperone-mediated protein transport | 1.286122e-2 |
GO:0071816 | tail-anchored membrane protein insertion into ER membrane | 1.286122e-2 |
GO:0032897 | negative regulation of viral transcription | 1.320815e-2 |
GO:0009651 | response to salt stress | 1.322732e-2 |
GO:0031576 | G2/M transition checkpoint | 1.360250e-2 |
GO:0032060 | bleb assembly | 1.372197e-2 |
GO:0021561 | facial nerve development | 1.372197e-2 |
GO:0090128 | regulation of synapse maturation | 1.373397e-2 |
GO:0006663 | platelet activating factor biosynthetic process | 1.385191e-2 |
GO:0000725 | recombinational repair | 1.423373e-2 |
GO:0042274 | ribosomal small subunit biogenesis | 1.424766e-2 |
GO:0007635 | chemosensory behavior | 1.426974e-2 |
GO:0072089 | stem cell proliferation | 1.428322e-2 |
GO:0043922 | negative regulation by host of viral transcription | 1.432715e-2 |
GO:0023035 | CD40 signaling pathway | 1.462244e-2 |
GO:0021933 | radial glia guided migration of cerebellar granule cell | 1.462244e-2 |
GO:0042418 | epinephrine biosynthetic process | 1.462244e-2 |
GO:0042946 | glucoside transport | 1.462244e-2 |
GO:0019068 | virion assembly | 1.462244e-2 |
GO:0019358 | nicotinate nucleotide salvage | 1.462244e-2 |
GO:0006585 | dopamine biosynthetic process from tyrosine | 1.462244e-2 |
GO:0006781 | succinyl-CoA pathway | 1.462244e-2 |
GO:0051084 | 'de novo' posttranslational protein folding | 1.463225e-2 |
GO:0071603 | endothelial cell-cell adhesion | 1.477752e-2 |
GO:0097119 | postsynaptic density protein 95 clustering | 1.504416e-2 |
GO:0097104 | postsynaptic membrane assembly | 1.504416e-2 |
GO:0050747 | positive regulation of lipoprotein metabolic process | 1.517193e-2 |
GO:0006378 | mRNA polyadenylation | 1.526098e-2 |
GO:0060383 | positive regulation of DNA strand elongation | 1.565084e-2 |
GO:2001037 | positive regulation of tongue muscle cell differentiation | 1.565084e-2 |
GO:0048561 | establishment of organ orientation | 1.565084e-2 |
GO:0097152 | mesenchymal cell apoptosis | 1.565084e-2 |
GO:0060982 | coronary artery morphogenesis | 1.565084e-2 |
GO:0042335 | cuticle development | 1.565084e-2 |
GO:0007388 | posterior compartment specification | 1.565084e-2 |
GO:0007387 | anterior compartment pattern formation | 1.565084e-2 |
GO:0019478 | D-amino acid catabolic process | 1.565084e-2 |
GO:2000373 | positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity | 1.572150e-2 |
GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter | 1.572150e-2 |
GO:0046599 | regulation of centriole replication | 1.572150e-2 |
GO:0007341 | penetration of zona pellucida | 1.572150e-2 |
GO:0070672 | response to interleukin-15 | 1.582154e-2 |
GO:0071322 | cellular response to carbohydrate stimulus | 1.597618e-2 |
GO:0035105 | sterol regulatory element binding protein import into nucleus | 1.599520e-2 |
GO:0003218 | cardiac left ventricle formation | 1.599520e-2 |
GO:0052066 | entry of symbiont into host cell by promotion of host phagocytosis | 1.601022e-2 |
GO:0035635 | entry of bacterium into host cell | 1.601022e-2 |
GO:0001834 | trophectodermal cell proliferation | 1.601022e-2 |
GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation | 1.601022e-2 |
GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition | 1.601022e-2 |
GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin | 1.625469e-2 |
GO:0031584 | activation of phospholipase D activity | 1.644724e-2 |
GO:0010912 | positive regulation of isomerase activity | 1.680499e-2 |
GO:0050775 | positive regulation of dendrite morphogenesis | 1.693146e-2 |
GO:0016925 | protein sumoylation | 1.713574e-2 |
GO:0031119 | tRNA pseudouridine synthesis | 1.714314e-2 |
GO:0034241 | positive regulation of macrophage fusion | 1.714314e-2 |
GO:0071279 | cellular response to cobalt ion | 1.714314e-2 |
GO:0010637 | negative regulation of mitochondrial fusion | 1.714314e-2 |
GO:0000472 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.714314e-2 |
GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.714314e-2 |
GO:0007100 | mitotic centrosome separation | 1.714314e-2 |
GO:0042278 | purine nucleoside metabolic process | 1.719155e-2 |
GO:0021604 | cranial nerve structural organization | 1.766960e-2 |
GO:0071503 | response to heparin | 1.766960e-2 |
GO:0009048 | dosage compensation, by inactivation of X chromosome | 1.779808e-2 |
GO:0006422 | aspartyl-tRNA aminoacylation | 1.779808e-2 |
GO:0048532 | anatomical structure arrangement | 1.796933e-2 |
GO:0042104 | positive regulation of activated T cell proliferation | 1.806371e-2 |
GO:0061110 | dense core granule biogenesis | 1.838827e-2 |
GO:0090331 | negative regulation of platelet aggregation | 1.838827e-2 |
GO:0061108 | seminal vesicle epithelium development | 1.838827e-2 |
GO:0042628 | mating plug formation | 1.838827e-2 |
GO:0030263 | apoptotic chromosome condensation | 1.838827e-2 |
GO:0035441 | cell migration involved in vasculogenesis | 1.838827e-2 |
GO:0035307 | positive regulation of protein dephosphorylation | 1.846770e-2 |
GO:0006538 | glutamate catabolic process | 1.867169e-2 |
GO:0015881 | creatine transport | 1.873171e-2 |
GO:0070889 | platelet alpha granule organization | 1.873171e-2 |
GO:0015739 | sialic acid transport | 1.873171e-2 |
GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation | 1.873171e-2 |
GO:0000237 | leptotene | 1.873171e-2 |
GO:0090031 | positive regulation of steroid hormone biosynthetic process | 1.897987e-2 |
GO:0006401 | RNA catabolic process | 1.919976e-2 |
GO:0032049 | cardiolipin biosynthetic process | 1.920228e-2 |
GO:0019067 | viral assembly, maturation, egress, and release | 1.926917e-2 |
GO:0060911 | cardiac cell fate commitment | 1.940471e-2 |
GO:0008355 | olfactory learning | 1.950016e-2 |
GO:0000959 | mitochondrial RNA metabolic process | 1.952820e-2 |
GO:0097116 | gephyrin clustering | 1.956712e-2 |
GO:0071333 | cellular response to glucose stimulus | 1.968413e-2 |
GO:0009264 | deoxyribonucleotide catabolic process | 2.026429e-2 |
GO:0021871 | forebrain regionalization | 2.038154e-2 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 2.042590e-2 |
GO:0000086 | G2/M transition of mitotic cell cycle | 2.056186e-2 |
GO:0060956 | endocardial cell differentiation | 2.059848e-2 |
GO:0001732 | formation of translation initiation complex | 2.059848e-2 |
GO:0071671 | regulation of smooth muscle cell chemotaxis | 2.068766e-2 |
GO:0003062 | regulation of heart rate by chemical signal | 2.068766e-2 |
GO:0003323 | type B pancreatic cell development | 2.094074e-2 |
GO:0030490 | maturation of SSU-rRNA | 2.102344e-2 |
GO:0046952 | ketone body catabolic process | 2.102670e-2 |
GO:0046939 | nucleotide phosphorylation | 2.110838e-2 |
GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 2.128516e-2 |
GO:0006686 | sphingomyelin biosynthetic process | 2.136135e-2 |
GO:0051154 | negative regulation of striated muscle cell differentiation | 2.166687e-2 |
GO:0031440 | regulation of mRNA 3'-end processing | 2.192273e-2 |
GO:0015919 | peroxisomal membrane transport | 2.199560e-2 |
GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter | 2.223778e-2 |
GO:0006359 | regulation of transcription from RNA polymerase III promoter | 2.226535e-2 |
GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis | 2.248371e-2 |
GO:0021602 | cranial nerve morphogenesis | 2.255107e-2 |
GO:0080154 | regulation of fertilization | 2.280158e-2 |
GO:2000438 | negative regulation of monocyte extravasation | 2.280158e-2 |
GO:0044314 | protein K27-linked ubiquitination | 2.280158e-2 |
GO:0035723 | interleukin-15-mediated signaling pathway | 2.280158e-2 |
GO:0006481 | C-terminal protein methylation | 2.280158e-2 |
GO:0035724 | CD24 biosynthetic process | 2.280158e-2 |
GO:0060058 | positive regulation of apoptosis involved in mammary gland involution | 2.285924e-2 |
GO:0035306 | positive regulation of dephosphorylation | 2.317057e-2 |
GO:0072109 | glomerular mesangium development | 2.324770e-2 |
GO:0045720 | negative regulation of integrin biosynthetic process | 2.392094e-2 |
GO:0060520 | activation of prostate induction by androgen receptor signaling pathway | 2.392094e-2 |
GO:0019102 | male somatic sex determination | 2.392094e-2 |
GO:0002380 | immunoglobulin secretion involved in immune response | 2.392094e-2 |
GO:0021678 | third ventricle development | 2.392217e-2 |
GO:0018095 | protein polyglutamylation | 2.397675e-2 |
GO:2000045 | regulation of G1/S transition of mitotic cell cycle | 2.435473e-2 |
GO:0055014 | atrial cardiac muscle cell development | 2.448515e-2 |
GO:0009394 | 2'-deoxyribonucleotide metabolic process | 2.454437e-2 |
GO:0022617 | extracellular matrix disassembly | 2.456403e-2 |
GO:0006402 | mRNA catabolic process | 2.456661e-2 |
GO:0033002 | muscle cell proliferation | 2.467258e-2 |
GO:0046015 | regulation of transcription by glucose | 2.505730e-2 |
GO:0008654 | phospholipid biosynthetic process | 2.511144e-2 |
GO:0009151 | purine deoxyribonucleotide metabolic process | 2.519447e-2 |
GO:0031017 | exocrine pancreas development | 2.533075e-2 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 2.565157e-2 |
GO:0006476 | protein deacetylation | 2.635273e-2 |
GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine | 2.670134e-2 |
GO:0001709 | cell fate determination | 2.679868e-2 |
GO:0046755 | non-lytic virus budding | 2.682741e-2 |
GO:0002030 | inhibitory G-protein coupled receptor phosphorylation | 2.682741e-2 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.682741e-2 |
GO:0006353 | transcription termination, DNA-dependent | 2.683158e-2 |
GO:0051645 | Golgi localization | 2.708575e-2 |
GO:0009642 | response to light intensity | 2.708575e-2 |
GO:0021530 | spinal cord oligodendrocyte cell fate specification | 2.713603e-2 |
GO:0010159 | specification of organ position | 2.713603e-2 |
GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin | 2.727651e-2 |
GO:0072061 | inner medullary collecting duct development | 2.755864e-2 |
GO:0072060 | outer medullary collecting duct development | 2.755864e-2 |
GO:0016332 | establishment or maintenance of polarity of embryonic epithelium | 2.755864e-2 |
GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase | 2.757730e-2 |
GO:0002691 | regulation of cellular extravasation | 2.757730e-2 |
GO:0016575 | histone deacetylation | 2.833903e-2 |
GO:0016180 | snRNA processing | 2.853160e-2 |
GO:0060044 | negative regulation of cardiac muscle cell proliferation | 2.853160e-2 |
GO:0046469 | platelet activating factor metabolic process | 2.857166e-2 |
GO:0015793 | glycerol transport | 2.857166e-2 |
GO:0007096 | regulation of exit from mitosis | 2.865521e-2 |
GO:0009401 | phosphoenolpyruvate-dependent sugar phosphotransferase system | 2.872863e-2 |
GO:0035445 | borate transmembrane transport | 2.872863e-2 |
GO:0051126 | negative regulation of actin nucleation | 2.872863e-2 |
GO:0034766 | negative regulation of ion transmembrane transport | 2.872863e-2 |
GO:0001832 | blastocyst growth | 2.883773e-2 |
GO:0048075 | positive regulation of eye pigmentation | 2.893829e-2 |
GO:0006313 | transposition, DNA-mediated | 2.893829e-2 |
GO:0046951 | ketone body biosynthetic process | 2.897402e-2 |
GO:0045081 | negative regulation of interleukin-10 biosynthetic process | 2.897402e-2 |
GO:0072298 | regulation of metanephric glomerulus development | 2.928540e-2 |
GO:0070934 | CRD-mediated mRNA stabilization | 2.991651e-2 |
GO:0021783 | preganglionic parasympathetic nervous system development | 3.008662e-2 |
GO:0042769 | DNA damage response, detection of DNA damage | 3.010991e-2 |
GO:0002523 | leukocyte migration involved in inflammatory response | 3.036848e-2 |
GO:0048708 | astrocyte differentiation | 3.048346e-2 |
GO:0007619 | courtship behavior | 3.052778e-2 |
GO:0071673 | positive regulation of smooth muscle cell chemotaxis | 3.052778e-2 |
GO:0003329 | pancreatic PP cell fate commitment | 3.052778e-2 |
GO:0003326 | pancreatic A cell fate commitment | 3.052778e-2 |
GO:0031123 | RNA 3'-end processing | 3.067999e-2 |
GO:0010626 | negative regulation of Schwann cell proliferation | 3.068385e-2 |
GO:0031572 | G2/M transition DNA damage checkpoint | 3.074987e-2 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 3.102772e-2 |
GO:0072537 | fibroblast activation | 3.102783e-2 |
GO:0070407 | oxidation-dependent protein catabolic process | 3.102783e-2 |
GO:0009399 | nitrogen fixation | 3.102783e-2 |
GO:0042414 | epinephrine metabolic process | 3.102783e-2 |
GO:0019098 | reproductive behavior | 3.106281e-2 |
GO:0035461 | vitamin transmembrane transport | 3.129679e-2 |
GO:0060318 | definitive erythrocyte differentiation | 3.148653e-2 |
GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter | 3.148653e-2 |
GO:0072363 | regulation of glycolysis by positive regulation of transcription from RNA polymerase II promoter | 3.148653e-2 |
GO:0035519 | protein K29-linked ubiquitination | 3.148653e-2 |
GO:0002034 | regulation of blood vessel size by renin-angiotensin | 3.148653e-2 |
GO:0007386 | compartment pattern specification | 3.161345e-2 |
GO:0048560 | establishment of anatomical structure orientation | 3.222912e-2 |
GO:0097090 | presynaptic membrane organization | 3.260230e-2 |
GO:0035601 | protein deacylation | 3.272921e-2 |
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 3.296414e-2 |
GO:0035304 | regulation of protein dephosphorylation | 3.330533e-2 |
GO:0045760 | positive regulation of action potential | 3.391758e-2 |
GO:0009200 | deoxyribonucleoside triphosphate metabolic process | 3.412132e-2 |
GO:0051036 | regulation of endosome size | 3.425784e-2 |
GO:0090035 | positive regulation of cellular chaperone-mediated protein complex assembly | 3.425784e-2 |
GO:0046333 | octopamine metabolic process | 3.457245e-2 |
GO:0042309 | homoiothermy | 3.457245e-2 |
GO:0042048 | olfactory behavior | 3.457245e-2 |
GO:0003097 | renal water transport | 3.502091e-2 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 3.511404e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0022402 | cell cycle process | 9.911306e-14 |
GO:0007049 | cell cycle | 3.330392e-11 |
GO:0000279 | M phase | 1.123466e-10 |
GO:0090224 | regulation of spindle organization | 1.429657e-10 |
GO:0048285 | organelle fission | 1.882058e-9 |
GO:0022403 | cell cycle phase | 1.962454e-9 |
GO:0007067 | mitosis | 1.539068e-8 |
GO:0000087 | M phase of mitotic cell cycle | 4.431558e-8 |
GO:0000278 | mitotic cell cycle | 1.499554e-7 |
GO:0034587 | piRNA metabolic process | 4.041982e-7 |
GO:0010564 | regulation of cell cycle process | 7.293795e-7 |
GO:0090342 | regulation of cell aging | 1.017752e-6 |
GO:0060236 | regulation of mitotic spindle organization | 1.602567e-6 |
GO:0046605 | regulation of centrosome cycle | 1.860177e-6 |
GO:0046479 | glycosphingolipid catabolic process | 2.460389e-6 |
GO:0007059 | chromosome segregation | 4.432518e-6 |
GO:0032203 | telomere formation via telomerase | 5.489704e-6 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 9.968322e-6 |
GO:0060160 | negative regulation of dopamine receptor signaling pathway | 1.087249e-5 |
GO:0007140 | male meiosis | 1.279064e-5 |
GO:0051973 | positive regulation of telomerase activity | 1.368312e-5 |
GO:0090234 | regulation of kinetochore assembly | 2.104610e-5 |
GO:0090169 | regulation of spindle assembly | 2.104610e-5 |
GO:0006396 | RNA processing | 2.278625e-5 |
GO:0016071 | mRNA metabolic process | 2.289645e-5 |
GO:0051726 | regulation of cell cycle | 2.347983e-5 |
GO:0046604 | positive regulation of mitotic centrosome separation | 2.592880e-5 |
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 2.668338e-5 |
GO:0007052 | mitotic spindle organization | 2.830285e-5 |
GO:0045175 | basal protein localization | 3.686454e-5 |
GO:0010388 | cullin deneddylation | 5.511003e-5 |
GO:0032200 | telomere organization | 6.343249e-5 |
GO:0032202 | telomere assembly | 6.733535e-5 |
GO:0071158 | positive regulation of cell cycle arrest | 6.904954e-5 |
GO:0006289 | nucleotide-excision repair | 1.132010e-4 |
GO:0071156 | regulation of cell cycle arrest | 1.218097e-4 |
GO:0031109 | microtubule polymerization or depolymerization | 1.458872e-4 |
GO:0030308 | negative regulation of cell growth | 1.464603e-4 |
GO:0070507 | regulation of microtubule cytoskeleton organization | 1.534825e-4 |
GO:0006397 | mRNA processing | 1.869430e-4 |
GO:0007050 | cell cycle arrest | 2.112208e-4 |
GO:0043316 | cytotoxic T cell degranulation | 2.337892e-4 |
GO:0000226 | microtubule cytoskeleton organization | 2.400833e-4 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 2.571788e-4 |
GO:0090399 | replicative senescence | 2.766562e-4 |
GO:0042256 | mature ribosome assembly | 2.813995e-4 |
GO:0060556 | regulation of vitamin D biosynthetic process | 2.859138e-4 |
GO:0006983 | ER overload response | 2.876473e-4 |
GO:0030952 | establishment or maintenance of cytoskeleton polarity | 3.086196e-4 |
GO:0035928 | rRNA import into mitochondrion | 3.120817e-4 |
GO:0046015 | regulation of transcription by glucose | 3.784642e-4 |
GO:0006657 | CDP-choline pathway | 3.784642e-4 |
GO:0000070 | mitotic sister chromatid segregation | 3.857386e-4 |
GO:0007051 | spindle organization | 4.022088e-4 |
GO:0008616 | queuosine biosynthetic process | 4.025818e-4 |
GO:0015879 | carnitine transport | 4.080542e-4 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 4.248456e-4 |
GO:0018009 | N-terminal peptidyl-L-cysteine N-palmitoylation | 4.363153e-4 |
GO:0010957 | negative regulation of vitamin D biosynthetic process | 4.426131e-4 |
GO:0090049 | regulation of cell migration involved in sprouting angiogenesis | 4.550019e-4 |
GO:0030950 | establishment or maintenance of actin cytoskeleton polarity | 4.648618e-4 |
GO:0072422 | signal transduction involved in DNA damage checkpoint | 4.928764e-4 |
GO:0051301 | cell division | 5.943693e-4 |
GO:0032886 | regulation of microtubule-based process | 5.992490e-4 |
GO:0051297 | centrosome organization | 6.067288e-4 |
GO:0007346 | regulation of mitotic cell cycle | 6.238611e-4 |
GO:0042335 | cuticle development | 6.321606e-4 |
GO:0006259 | DNA metabolic process | 6.380667e-4 |
GO:0031577 | spindle checkpoint | 6.472263e-4 |
GO:0007525 | somatic muscle development | 6.481173e-4 |
GO:0002678 | positive regulation of chronic inflammatory response | 6.481173e-4 |
GO:0006433 | prolyl-tRNA aminoacylation | 6.533386e-4 |
GO:0060026 | convergent extension | 6.797452e-4 |
GO:0046092 | deoxycytidine metabolic process | 6.816227e-4 |
GO:0008617 | guanosine metabolic process | 6.816227e-4 |
GO:0034498 | early endosome to Golgi transport | 6.816227e-4 |
GO:0000819 | sister chromatid segregation | 6.983121e-4 |
GO:2000543 | positive regulation of gastrulation | 7.591093e-4 |
GO:0042267 | natural killer cell mediated cytotoxicity | 8.065431e-4 |
GO:0043687 | post-translational protein modification | 8.065431e-4 |
GO:0010225 | response to UV-C | 8.433061e-4 |
GO:0048484 | enteric nervous system development | 8.518206e-4 |
GO:0000075 | cell cycle checkpoint | 8.959897e-4 |
GO:0071636 | positive regulation of transforming growth factor beta production | 9.302985e-4 |
GO:0030433 | ER-associated protein catabolic process | 9.795124e-4 |
GO:0072404 | signal transduction involved in G1/S transition checkpoint | 1.019734e-3 |
GO:0035282 | segmentation | 1.043343e-3 |
GO:0001778 | plasma membrane repair | 1.133500e-3 |
GO:0008635 | activation of caspase activity by cytochrome c | 1.153324e-3 |
GO:0051029 | rRNA transport | 1.200950e-3 |
GO:0009082 | branched chain family amino acid biosynthetic process | 1.200950e-3 |
GO:0090184 | positive regulation of kidney development | 1.213566e-3 |
GO:0060600 | dichotomous subdivision of an epithelial terminal unit | 1.311535e-3 |
GO:0046477 | glycosylceramide catabolic process | 1.340729e-3 |
GO:0001913 | T cell mediated cytotoxicity | 1.349509e-3 |
GO:0032915 | positive regulation of transforming growth factor beta2 production | 1.349509e-3 |
GO:0060795 | cell fate commitment involved in formation of primary germ layers | 1.374968e-3 |
GO:0035621 | ER to Golgi ceramide transport | 1.381399e-3 |
GO:0000237 | leptotene | 1.381399e-3 |
GO:0051276 | chromosome organization | 1.390543e-3 |
GO:0007017 | microtubule-based process | 1.433097e-3 |
GO:0031023 | microtubule organizing center organization | 1.441789e-3 |
GO:0070366 | regulation of hepatocyte differentiation | 1.444057e-3 |
GO:0072268 | pattern specification involved in metanephros development | 1.444057e-3 |
GO:0050771 | negative regulation of axonogenesis | 1.448184e-3 |
GO:0051972 | regulation of telomerase activity | 1.496563e-3 |
GO:0006260 | DNA replication | 1.497708e-3 |
GO:0051030 | snRNA transport | 1.498954e-3 |
GO:0060179 | male mating behavior | 1.498954e-3 |
GO:0046416 | D-amino acid metabolic process | 1.498954e-3 |
GO:0000733 | DNA strand renaturation | 1.503244e-3 |
GO:0007093 | mitotic cell cycle checkpoint | 1.534569e-3 |
GO:0006666 | 3-keto-sphinganine metabolic process | 1.534874e-3 |
GO:0045004 | DNA replication proofreading | 1.534874e-3 |
GO:0006409 | tRNA export from nucleus | 1.534874e-3 |
GO:0045600 | positive regulation of fat cell differentiation | 1.543020e-3 |
GO:0072395 | signal transduction involved in cell cycle checkpoint | 1.671782e-3 |
GO:0032525 | somite rostral/caudal axis specification | 1.783739e-3 |
GO:0008380 | RNA splicing | 1.807367e-3 |
GO:0016926 | protein desumoylation | 1.815860e-3 |
GO:0060029 | convergent extension involved in organogenesis | 1.816131e-3 |
GO:0072668 | tubulin complex biogenesis | 1.832468e-3 |
GO:0006457 | protein folding | 1.833322e-3 |
GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 1.833641e-3 |
GO:0043536 | positive regulation of blood vessel endothelial cell migration | 1.926846e-3 |
GO:0071634 | regulation of transforming growth factor beta production | 2.057773e-3 |
GO:0045786 | negative regulation of cell cycle | 2.061440e-3 |
GO:0042147 | retrograde transport, endosome to Golgi | 2.115169e-3 |
GO:0032514 | positive regulation of protein phosphatase type 2B activity | 2.149222e-3 |
GO:0060134 | prepulse inhibition | 2.170621e-3 |
GO:0046607 | positive regulation of centrosome cycle | 2.201120e-3 |
GO:0046602 | regulation of mitotic centrosome separation | 2.201120e-3 |
GO:0043148 | mitotic spindle stabilization | 2.201120e-3 |
GO:0009443 | pyridoxal 5'-phosphate salvage | 2.365909e-3 |
GO:0061015 | snRNA import into nucleus | 2.365909e-3 |
GO:0006683 | galactosylceramide catabolic process | 2.365909e-3 |
GO:0090231 | regulation of spindle checkpoint | 2.380727e-3 |
GO:0071173 | spindle assembly checkpoint | 2.380727e-3 |
GO:0051983 | regulation of chromosome segregation | 2.425672e-3 |
GO:0006680 | glucosylceramide catabolic process | 2.442216e-3 |
GO:0035284 | brain segmentation | 2.447945e-3 |
GO:0002309 | T cell proliferation involved in immune response | 2.506363e-3 |
GO:0045749 | negative regulation of S phase of mitotic cell cycle | 2.545452e-3 |
GO:0006184 | GTP catabolic process | 2.591258e-3 |
GO:0000432 | positive regulation of transcription from RNA polymerase II promoter by glucose | 2.787131e-3 |
GO:0006651 | diacylglycerol biosynthetic process | 2.787131e-3 |
GO:0046039 | GTP metabolic process | 2.799023e-3 |
GO:0051036 | regulation of endosome size | 2.861006e-3 |
GO:0072215 | regulation of metanephros development | 2.908176e-3 |
GO:0045014 | negative regulation of transcription by glucose | 2.947788e-3 |
GO:0032365 | intracellular lipid transport | 2.959401e-3 |
GO:0090403 | oxidative stress-induced premature senescence | 2.967749e-3 |
GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis | 2.967749e-3 |
GO:0042823 | pyridoxal phosphate biosynthetic process | 2.991403e-3 |
GO:0010721 | negative regulation of cell development | 3.026115e-3 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 3.120888e-3 |
GO:0031497 | chromatin assembly | 3.154136e-3 |
GO:0034067 | protein localization in Golgi apparatus | 3.167085e-3 |
GO:0007021 | tubulin complex assembly | 3.179356e-3 |
GO:2000381 | negative regulation of mesoderm development | 3.194946e-3 |
GO:0051594 | detection of glucose | 3.194946e-3 |
GO:0051321 | meiotic cell cycle | 3.222450e-3 |
GO:0071777 | positive regulation of cell cycle cytokinesis | 3.377401e-3 |
GO:0048539 | bone marrow development | 3.406314e-3 |
GO:0031576 | G2/M transition checkpoint | 3.451735e-3 |
GO:0006306 | DNA methylation | 3.475757e-3 |
GO:0071479 | cellular response to ionizing radiation | 3.512611e-3 |
GO:0090103 | cochlea morphogenesis | 3.570133e-3 |
GO:0016197 | endosome transport | 3.646444e-3 |
GO:0008637 | apoptotic mitochondrial changes | 3.759650e-3 |
GO:0060491 | regulation of cell projection assembly | 3.812057e-3 |
GO:0043320 | natural killer cell degranulation | 3.829535e-3 |
GO:0045542 | positive regulation of cholesterol biosynthetic process | 3.901950e-3 |
GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching | 3.978267e-3 |
GO:0031572 | G2/M transition DNA damage checkpoint | 4.000443e-3 |
GO:0010046 | response to mycotoxin | 4.057455e-3 |
GO:0007060 | male meiosis chromosome segregation | 4.112485e-3 |
GO:0001705 | ectoderm formation | 4.112485e-3 |
GO:0035372 | protein localization to microtubule | 4.128539e-3 |
GO:2000772 | regulation of cellular senescence | 4.358012e-3 |
GO:0042634 | regulation of hair cycle | 4.422771e-3 |
GO:0032909 | regulation of transforming growth factor beta2 production | 4.504820e-3 |
GO:0006309 | DNA fragmentation involved in apoptotic nuclear change | 4.598975e-3 |
GO:0050935 | iridophore differentiation | 4.727393e-3 |
GO:0048937 | lateral line nerve glial cell development | 4.727393e-3 |
GO:0000077 | DNA damage checkpoint | 4.752690e-3 |
GO:0019377 | glycolipid catabolic process | 4.806928e-3 |
GO:0060806 | negative regulation of cell differentiation involved in embryonic placenta development | 4.809578e-3 |
GO:0018364 | peptidyl-glutamine methylation | 4.809578e-3 |
GO:0001710 | mesodermal cell fate commitment | 4.939196e-3 |
GO:0055119 | relaxation of cardiac muscle | 4.964882e-3 |
GO:0031571 | mitotic cell cycle G1/S transition DNA damage checkpoint | 5.014629e-3 |
GO:0061053 | somite development | 5.105141e-3 |
GO:0033169 | histone H3-K9 demethylation | 5.176481e-3 |
GO:0043558 | regulation of translational initiation in response to stress | 5.216200e-3 |
GO:0072661 | protein targeting to plasma membrane | 5.380114e-3 |
GO:0031247 | actin rod assembly | 5.380114e-3 |
GO:0060443 | mammary gland morphogenesis | 5.410036e-3 |
GO:0031570 | DNA integrity checkpoint | 5.497400e-3 |
GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway | 5.535862e-3 |
GO:0072285 | mesenchymal to epithelial transition involved in metanephric renal vesicle formation | 5.535862e-3 |
GO:0060248 | detection of cell density by contact stimulus involved in contact inhibition | 5.535862e-3 |
GO:0090138 | regulation of actin cytoskeleton organization by cell-cell adhesion | 5.535862e-3 |
GO:0050983 | deoxyhypusine biosynthetic process from spermidine, using deoxyhypusine synthase | 5.535862e-3 |
GO:0007371 | ventral midline determination | 5.535862e-3 |
GO:0016142 | O-glycoside catabolic process | 5.535862e-3 |
GO:0007099 | centriole replication | 5.538086e-3 |
GO:0072175 | epithelial tube formation | 5.696775e-3 |
GO:0010595 | positive regulation of endothelial cell migration | 5.711474e-3 |
GO:0090344 | negative regulation of cell aging | 5.811733e-3 |
GO:0007126 | meiosis | 6.030836e-3 |
GO:0060603 | mammary gland duct morphogenesis | 6.045777e-3 |
GO:0000910 | cytokinesis | 6.075333e-3 |
GO:0071044 | histone mRNA catabolic process | 6.153027e-3 |
GO:0007635 | chemosensory behavior | 6.153027e-3 |
GO:0051491 | positive regulation of filopodium assembly | 6.186666e-3 |
GO:0000042 | protein targeting to Golgi | 6.249065e-3 |
GO:0034622 | cellular macromolecular complex assembly | 6.428278e-3 |
GO:0001756 | somitogenesis | 6.526371e-3 |
GO:0006333 | chromatin assembly or disassembly | 6.619294e-3 |
GO:0034436 | glycoprotein transport | 6.709397e-3 |
GO:0032074 | negative regulation of nuclease activity | 6.709397e-3 |
GO:0007019 | microtubule depolymerization | 6.709397e-3 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 6.761814e-3 |
GO:0001838 | embryonic epithelial tube formation | 6.870089e-3 |
GO:0050768 | negative regulation of neurogenesis | 6.927658e-3 |
GO:0007064 | mitotic sister chromatid cohesion | 6.959791e-3 |
GO:0051586 | positive regulation of dopamine uptake | 6.992357e-3 |
GO:0042048 | olfactory behavior | 6.992357e-3 |
GO:0008612 | peptidyl-lysine modification to hypusine | 6.997199e-3 |
GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 6.997199e-3 |
GO:0050821 | protein stabilization | 7.325655e-3 |
GO:0043519 | regulation of myosin II filament organization | 7.354965e-3 |
GO:0034088 | maintenance of mitotic sister chromatid cohesion | 7.354965e-3 |
GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I | 7.354965e-3 |
GO:0051545 | negative regulation of elastin biosynthetic process | 7.366448e-3 |
GO:0070179 | D-serine biosynthetic process | 7.460730e-3 |
GO:0006044 | N-acetylglucosamine metabolic process | 7.605576e-3 |
GO:0043570 | maintenance of DNA repeat elements | 7.686114e-3 |
GO:0061004 | pattern specification involved in kidney development | 7.739114e-3 |
GO:0033205 | cell cycle cytokinesis | 7.739291e-3 |
GO:0007141 | male meiosis I | 7.838583e-3 |
GO:0008078 | mesodermal cell migration | 7.884941e-3 |
GO:0060444 | branching involved in mammary gland duct morphogenesis | 7.968867e-3 |
GO:0090183 | regulation of kidney development | 8.033671e-3 |
GO:0090343 | positive regulation of cell aging | 8.063105e-3 |
GO:0032912 | negative regulation of transforming growth factor beta2 production | 8.274617e-3 |
GO:0051797 | regulation of hair follicle development | 8.327639e-3 |
GO:0006670 | sphingosine metabolic process | 8.470504e-3 |
GO:0010608 | posttranscriptional regulation of gene expression | 8.689946e-3 |
GO:0035117 | embryonic arm morphogenesis | 8.853577e-3 |
GO:0030521 | androgen receptor signaling pathway | 8.913780e-3 |
GO:0045926 | negative regulation of growth | 8.992038e-3 |
GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development | 9.077780e-3 |
GO:0046853 | inositol or phosphatidylinositol phosphorylation | 9.077780e-3 |
GO:0090193 | positive regulation of glomerulus development | 9.114239e-3 |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 9.114239e-3 |
GO:0009103 | lipopolysaccharide biosynthetic process | 9.684659e-3 |
GO:0018076 | N-terminal peptidyl-lysine acetylation | 9.863732e-3 |
GO:0010948 | negative regulation of cell cycle process | 1.004253e-2 |
GO:0050775 | positive regulation of dendrite morphogenesis | 1.007744e-2 |
GO:0031647 | regulation of protein stability | 1.015111e-2 |
GO:0034231 | islet amyloid polypeptide processing | 1.036576e-2 |
GO:0046293 | formaldehyde biosynthetic process | 1.036576e-2 |
GO:0032474 | otolith morphogenesis | 1.036576e-2 |
GO:0034230 | enkephalin processing | 1.036576e-2 |
GO:0071174 | mitotic cell cycle spindle checkpoint | 1.048478e-2 |
GO:0060744 | mammary gland branching involved in thelarche | 1.050075e-2 |
GO:0045727 | positive regulation of translation | 1.050567e-2 |
GO:0046519 | sphingoid metabolic process | 1.069631e-2 |
GO:0071585 | detoxification of cadmium ion | 1.093463e-2 |
GO:0048178 | negative regulation of hepatocyte growth factor biosynthetic process | 1.093463e-2 |
GO:0048846 | axon extension involved in axon guidance | 1.106131e-2 |
GO:0070367 | negative regulation of hepatocyte differentiation | 1.121558e-2 |
GO:0006689 | ganglioside catabolic process | 1.121558e-2 |
GO:0030149 | sphingolipid catabolic process | 1.148561e-2 |
GO:0010591 | regulation of lamellipodium assembly | 1.148561e-2 |
GO:0000723 | telomere maintenance | 1.168173e-2 |
GO:0090307 | spindle assembly involved in mitosis | 1.182480e-2 |
GO:0048668 | collateral sprouting | 1.182480e-2 |
GO:0035279 | mRNA cleavage involved in gene silencing by miRNA | 1.182480e-2 |
GO:0010457 | centriole-centriole cohesion | 1.182480e-2 |
GO:0060562 | epithelial tube morphogenesis | 1.188446e-2 |
GO:0035269 | protein O-linked mannosylation | 1.196468e-2 |
GO:0006481 | C-terminal protein methylation | 1.196468e-2 |
GO:0022617 | extracellular matrix disassembly | 1.200625e-2 |
GO:0048570 | notochord morphogenesis | 1.200625e-2 |
GO:0034621 | cellular macromolecular complex subunit organization | 1.208537e-2 |
GO:0043535 | regulation of blood vessel endothelial cell migration | 1.233885e-2 |
GO:2000602 | regulation of interphase of mitotic cell cycle | 1.249005e-2 |
GO:0050658 | RNA transport | 1.249375e-2 |
GO:0034660 | ncRNA metabolic process | 1.251660e-2 |
GO:0048255 | mRNA stabilization | 1.260430e-2 |
GO:0022613 | ribonucleoprotein complex biogenesis | 1.287921e-2 |
GO:0051489 | regulation of filopodium assembly | 1.294898e-2 |
GO:0048880 | sensory system development | 1.303800e-2 |
GO:0000185 | activation of MAPKKK activity | 1.303800e-2 |
GO:0046426 | negative regulation of JAK-STAT cascade | 1.323910e-2 |
GO:0009083 | branched chain family amino acid catabolic process | 1.333175e-2 |
GO:2000761 | positive regulation of N-terminal peptidyl-lysine acetylation | 1.362250e-2 |
GO:0035910 | ascending aorta morphogenesis | 1.362250e-2 |
GO:0032423 | regulation of mismatch repair | 1.368833e-2 |
GO:0018410 | C-terminal protein amino acid modification | 1.368833e-2 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 1.387714e-2 |
GO:0006287 | base-excision repair, gap-filling | 1.387714e-2 |
GO:0071843 | cellular component biogenesis at cellular level | 1.388302e-2 |
GO:0042273 | ribosomal large subunit biogenesis | 1.392935e-2 |
GO:0042074 | cell migration involved in gastrulation | 1.498209e-2 |
GO:0060282 | positive regulation of oocyte development | 1.500559e-2 |
GO:0060281 | regulation of oocyte development | 1.500559e-2 |
GO:0090179 | planar cell polarity pathway involved in neural tube closure | 1.509719e-2 |
GO:0071845 | cellular component disassembly at cellular level | 1.518945e-2 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 1.530139e-2 |
GO:0000917 | barrier septum formation | 1.530139e-2 |
GO:0006334 | nucleosome assembly | 1.554042e-2 |
GO:0003350 | pulmonary myocardium development | 1.565527e-2 |
GO:0006323 | DNA packaging | 1.570455e-2 |
GO:0051482 | elevation of cytosolic calcium ion concentration involved in G-protein signaling coupled to IP3 second messenger | 1.587477e-2 |
GO:0007063 | regulation of sister chromatid cohesion | 1.604539e-2 |
GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient | 1.617707e-2 |
GO:0010950 | positive regulation of endopeptidase activity | 1.617707e-2 |
GO:0007098 | centrosome cycle | 1.639704e-2 |
GO:0055099 | response to high density lipoprotein particle stimulus | 1.697361e-2 |
GO:0006467 | protein thiol-disulfide exchange | 1.697361e-2 |
GO:0021658 | rhombomere 3 morphogenesis | 1.697361e-2 |
GO:0030719 | P granule organization | 1.697648e-2 |
GO:0009313 | oligosaccharide catabolic process | 1.697648e-2 |
GO:0046814 | virion attachment, binding of host cell surface coreceptor | 1.698893e-2 |
GO:0043538 | regulation of actin phosphorylation | 1.698893e-2 |
GO:0072267 | metanephric capsule specification | 1.698893e-2 |
GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process | 1.698893e-2 |
GO:0019064 | viral envelope fusion with host membrane | 1.698893e-2 |
GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific | 1.698893e-2 |
GO:0016140 | O-glycoside metabolic process | 1.698893e-2 |
GO:0015969 | guanosine tetraphosphate metabolic process | 1.698893e-2 |
GO:0021586 | pons maturation | 1.698893e-2 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 1.718309e-2 |
GO:0032060 | bleb assembly | 1.718309e-2 |
GO:0045176 | apical protein localization | 1.727911e-2 |
GO:0006096 | glycolysis | 1.751137e-2 |
GO:0071108 | protein K48-linked deubiquitination | 1.753658e-2 |
GO:0051403 | stress-activated MAPK cascade | 1.753658e-2 |
GO:0002483 | antigen processing and presentation of endogenous peptide antigen | 1.753658e-2 |
GO:0016032 | viral reproduction | 1.759580e-2 |
GO:0003166 | bundle of His development | 1.761685e-2 |
GO:0045084 | positive regulation of interleukin-12 biosynthetic process | 1.829937e-2 |
GO:0008334 | histone mRNA metabolic process | 1.829937e-2 |
GO:0022411 | cellular component disassembly | 1.850434e-2 |
GO:0006403 | RNA localization | 1.851299e-2 |
GO:0061034 | olfactory bulb mitral cell layer development | 1.873964e-2 |
GO:0048755 | branching morphogenesis of a nerve | 1.873964e-2 |
GO:0090398 | cellular senescence | 1.890143e-2 |
GO:0060044 | negative regulation of cardiac muscle cell proliferation | 1.908338e-2 |
GO:0048793 | pronephros development | 1.908591e-2 |
GO:0022614 | membrane to membrane docking | 1.908591e-2 |
GO:0043046 | DNA methylation involved in gamete generation | 1.910864e-2 |
GO:0006891 | intra-Golgi vesicle-mediated transport | 1.910864e-2 |
GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway | 1.947254e-2 |
GO:0042866 | pyruvate biosynthetic process | 1.947254e-2 |
GO:0006498 | N-terminal protein lipidation | 1.947254e-2 |
GO:0000105 | histidine biosynthetic process | 1.947254e-2 |
GO:0006424 | glutamyl-tRNA aminoacylation | 1.947254e-2 |
GO:0007217 | tachykinin receptor signaling pathway | 1.958102e-2 |
GO:0055118 | negative regulation of cardiac muscle contraction | 1.958212e-2 |
GO:0006412 | translation | 1.972051e-2 |
GO:0007509 | mesoderm migration involved in gastrulation | 1.979403e-2 |
GO:0032916 | positive regulation of transforming growth factor beta3 production | 1.998779e-2 |
GO:0035148 | tube formation | 2.016587e-2 |
GO:0061181 | regulation of chondrocyte development | 2.050457e-2 |
GO:0001909 | leukocyte mediated cytotoxicity | 2.061910e-2 |
GO:0071955 | recycling endosome to Golgi transport | 2.062414e-2 |
GO:0070861 | regulation of protein exit from endoplasmic reticulum | 2.062414e-2 |
GO:0031129 | inductive cell-cell signaling | 2.062414e-2 |
GO:0034499 | late endosome to Golgi transport | 2.062414e-2 |
GO:0003337 | mesenchymal to epithelial transition involved in metanephros morphogenesis | 2.073565e-2 |
GO:0035852 | horizontal cell localization | 2.083502e-2 |
GO:2000768 | positive regulation of nephron tubule epithelial cell differentiation | 2.083502e-2 |
GO:0042376 | phylloquinone catabolic process | 2.083502e-2 |
GO:0035849 | nephric duct elongation | 2.083502e-2 |
GO:0035847 | uterine epithelium development | 2.083502e-2 |
GO:0010266 | response to vitamin B1 | 2.083502e-2 |
GO:0009949 | polarity specification of anterior/posterior axis | 2.083502e-2 |
GO:0035846 | oviduct epithelium development | 2.083502e-2 |
GO:0071826 | ribonucleoprotein complex subunit organization | 2.084063e-2 |
GO:0050901 | leukocyte tethering or rolling | 2.110724e-2 |
GO:0090068 | positive regulation of cell cycle process | 2.135527e-2 |
GO:0002553 | histamine secretion by mast cell | 2.157930e-2 |
GO:0002268 | follicular dendritic cell differentiation | 2.157930e-2 |
GO:0055094 | response to lipoprotein stimulus | 2.207197e-2 |
GO:0051590 | positive regulation of neurotransmitter transport | 2.221359e-2 |
GO:0051799 | negative regulation of hair follicle development | 2.221399e-2 |
GO:0051580 | regulation of neurotransmitter uptake | 2.223791e-2 |
GO:0009437 | carnitine metabolic process | 2.223791e-2 |
GO:0034637 | cellular carbohydrate biosynthetic process | 2.226837e-2 |
GO:0046902 | regulation of mitochondrial membrane permeability | 2.329112e-2 |
GO:0046125 | pyrimidine deoxyribonucleoside metabolic process | 2.335572e-2 |
GO:0033007 | negative regulation of mast cell activation involved in immune response | 2.335572e-2 |
GO:0002098 | tRNA wobble uridine modification | 2.335572e-2 |
GO:0022007 | convergent extension involved in neural plate elongation | 2.335572e-2 |
GO:0016331 | morphogenesis of embryonic epithelium | 2.337076e-2 |
GO:0032465 | regulation of cytokinesis | 2.349968e-2 |
GO:0051493 | regulation of cytoskeleton organization | 2.377750e-2 |
GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity | 2.386886e-2 |
GO:0031657 | regulation of cyclin-dependent protein kinase activity involved in G1/S | 2.397490e-2 |
GO:0031575 | mitotic cell cycle G1/S transition checkpoint | 2.416523e-2 |
GO:0045994 | positive regulation of translational initiation by iron | 2.417002e-2 |
GO:0061048 | negative regulation of branching involved in lung morphogenesis | 2.417002e-2 |
GO:2000976 | regulation of transcription from RNA polymerase II promoter involved in detection of glucose | 2.417002e-2 |
GO:0042706 | eye photoreceptor cell fate commitment | 2.417002e-2 |
GO:2000971 | negative regulation of detection of glucose | 2.417002e-2 |
GO:0000433 | negative regulation of transcription from RNA polymerase II promoter by glucose | 2.417002e-2 |
GO:0002037 | negative regulation of L-glutamate transport | 2.417002e-2 |
GO:0018242 | protein O-linked glycosylation via serine | 2.417002e-2 |
GO:0018243 | protein O-linked glycosylation via threonine | 2.417002e-2 |
GO:0034116 | positive regulation of heterotypic cell-cell adhesion | 2.417002e-2 |
GO:0010824 | regulation of centrosome duplication | 2.436112e-2 |
GO:0006040 | amino sugar metabolic process | 2.447570e-2 |
GO:0008156 | negative regulation of DNA replication | 2.447570e-2 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 2.449789e-2 |
GO:0006352 | transcription initiation, DNA-dependent | 2.454635e-2 |
GO:0000281 | cytokinesis after mitosis | 2.470982e-2 |
GO:0072300 | positive regulation of metanephric glomerulus development | 2.470982e-2 |
GO:0032781 | positive regulation of ATPase activity | 2.479231e-2 |
GO:2000379 | positive regulation of reactive oxygen species metabolic process | 2.488026e-2 |
GO:0001558 | regulation of cell growth | 2.491604e-2 |
GO:0033962 | cytoplasmic mRNA processing body assembly | 2.508954e-2 |
GO:0032910 | regulation of transforming growth factor beta3 production | 2.508954e-2 |
GO:0061035 | regulation of cartilage development | 2.529549e-2 |
GO:0042840 | D-glucuronate catabolic process | 2.546568e-2 |
GO:0045751 | negative regulation of Toll signaling pathway | 2.546568e-2 |
GO:0035582 | negative regulation of BMP signaling pathway by extracellular sequestering of BMP | 2.546568e-2 |
GO:0034776 | response to histamine | 2.546568e-2 |
GO:0060821 | inactivation of X chromosome by DNA methylation | 2.546568e-2 |
GO:0048790 | maintenance of presynaptic active zone structure | 2.546568e-2 |
GO:0006844 | acyl carnitine transport | 2.546568e-2 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 2.546568e-2 |
GO:0008049 | male courtship behavior | 2.546568e-2 |
GO:0018293 | protein-FAD linkage | 2.546568e-2 |
GO:0032790 | ribosome disassembly | 2.546568e-2 |
GO:0032543 | mitochondrial translation | 2.546568e-2 |
GO:0006354 | transcription elongation, DNA-dependent | 2.562762e-2 |
GO:0010470 | regulation of gastrulation | 2.580635e-2 |
GO:0014009 | glial cell proliferation | 2.593460e-2 |
GO:0070230 | positive regulation of lymphocyte apoptosis | 2.612369e-2 |
GO:0070874 | negative regulation of glycogen metabolic process | 2.663026e-2 |
GO:0035767 | endothelial cell chemotaxis | 2.676831e-2 |
GO:0003148 | outflow tract septum morphogenesis | 2.690401e-2 |
GO:0043137 | DNA replication, removal of RNA primer | 2.694996e-2 |
GO:0090096 | positive regulation of metanephric cap mesenchymal cell proliferation | 2.709448e-2 |
GO:0061304 | retinal blood vessel morphogenesis | 2.709448e-2 |
GO:0010594 | regulation of endothelial cell migration | 2.712662e-2 |
GO:0043313 | regulation of neutrophil degranulation | 2.768281e-2 |
GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis | 2.768281e-2 |
GO:0071103 | DNA conformation change | 2.782784e-2 |
GO:0018198 | peptidyl-cysteine modification | 2.813389e-2 |
GO:0045719 | negative regulation of glycogen biosynthetic process | 2.813389e-2 |
GO:0010592 | positive regulation of lamellipodium assembly | 2.813389e-2 |
GO:0046599 | regulation of centriole replication | 2.814414e-2 |
GO:0016540 | protein autoprocessing | 2.821914e-2 |
GO:0006401 | RNA catabolic process | 2.858493e-2 |
GO:0065004 | protein-DNA complex assembly | 2.872962e-2 |
GO:0010332 | response to gamma radiation | 2.880470e-2 |
GO:0042345 | regulation of NF-kappaB import into nucleus | 2.881942e-2 |
GO:0072126 | positive regulation of glomerular mesangial cell proliferation | 2.897829e-2 |
GO:0071506 | cellular response to mycophenolic acid | 2.897829e-2 |
GO:0006402 | mRNA catabolic process | 2.927396e-2 |
GO:0002352 | B cell negative selection | 2.953803e-2 |
GO:0006308 | DNA catabolic process | 3.014459e-2 |
GO:0000712 | resolution of meiotic recombination intermediates | 3.074918e-2 |
GO:0035507 | regulation of myosin-light-chain-phosphatase activity | 3.121962e-2 |
GO:0008652 | cellular amino acid biosynthetic process | 3.128680e-2 |
GO:0002326 | B cell lineage commitment | 3.162684e-2 |
GO:0048050 | post-embryonic eye morphogenesis | 3.189431e-2 |
GO:0048102 | autophagic cell death | 3.189431e-2 |
GO:0032784 | regulation of transcription elongation, DNA-dependent | 3.249632e-2 |
GO:0071779 | G1/S transition checkpoint | 3.253057e-2 |
GO:0006007 | glucose catabolic process | 3.297647e-2 |
GO:0090192 | regulation of glomerulus development | 3.315730e-2 |
GO:0051496 | positive regulation of stress fiber assembly | 3.333507e-2 |
GO:0006906 | vesicle fusion | 3.356903e-2 |
GO:0043301 | negative regulation of leukocyte degranulation | 3.367033e-2 |
GO:0034227 | tRNA thio-modification | 3.396469e-2 |
GO:2000383 | regulation of ectoderm development | 3.396469e-2 |
GO:0090009 | primitive streak formation | 3.421988e-2 |
GO:0034421 | post-translational protein acetylation | 3.431017e-2 |
GO:0008216 | spermidine metabolic process | 3.431017e-2 |
GO:0060561 | apoptosis involved in morphogenesis | 3.454024e-2 |
GO:0072283 | metanephric renal vesicle morphogenesis | 3.454024e-2 |
GO:0015074 | DNA integration | 3.456638e-2 |
GO:0006417 | regulation of translation | 3.458729e-2 |
GO:0000060 | protein import into nucleus, translocation | 3.462438e-2 |
GO:0006405 | RNA export from nucleus | 3.462438e-2 |
GO:0055091 | phospholipid homeostasis | 3.474083e-2 |
GO:0001841 | neural tube formation | 3.483273e-2 |
GO:0021696 | cerebellar cortex morphogenesis | 3.504207e-2 |
GO:0090312 | positive regulation of protein deacetylation | 3.530697e-2 |
GO:0032289 | central nervous system myelin formation | 3.560014e-2 |
GO:0046600 | negative regulation of centriole replication | 3.560014e-2 |
GO:0009299 | mRNA transcription | 3.560014e-2 |
GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus | 3.560014e-2 |